The old Chinese curse that runs ‘may you live in interesting times’ holds today much as it ever did. Two days after Donald ...

Pharmaceutical companies breathed a sigh of relief on Wednesday, but the tariff reprieve could prove fleeting.

Trump has repeatedly called April 2 “Liberation Day,” alluding to a more sweeping and aggressive set of tariffs. Leerink Partners analysts said that the risks from Trump’s tariffs on the biopharma ...

"themeId": "lct_653b7fa7fed115003648bab8", "clientId": "64772ae4d1d7dec0c5b716af", "liveblogId": "67ea5efb9b66b38dded9cb29"} ...

At Intel’s Vision 2025 conference, CEO Lip-Bu Tan took the stage in the first major appearance in his new role to describe ...

Leerink Partners analyst David Resinger warned his clients on Sunday that the tariff risks to the industry are ...

The NSE Nifty 50 ended 72.60 points or 0.31% lower at 23,519.35, while the BSE Sensex closed 191.51 points, or 0.25% down at ...

In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...

A short-term focus on corporation tax repatriation is a likely target of the Trump administration, owing to the complexity of ...

SINGAPORE] Boustead Singapore’s engineering and construction business unit, under its real estate solutions division Boustead ...

In addition, the Group's subsidiary Viva Biotech Shanghai was successfully restructured into a joint stock limited company on September 27, 2024, as the Group currently holds approximately 72.9% of ...

Total Revenues in 2024 reached $492 million, representing a 427% increase over prior yearProduct Revenues in 2024 reached $273 million, representing a 462% increase over prior yearAdjusted EBITDA in ...